ALB and diabetes mellitus: Just as glycation contribute to pathologic sequelae in conditions such as diabetes mellitus, carbamylation has been shown to change the properties of various enzymes, hormones etc., ultimately contributing to the deleterious effects of reduced kidney function.9 Carbamylation decelerates HSA function and carbamylated-HSA (c-HSA) is more prone to oxidative damage.10 Carbamylation derived products (CDPs) are highly reactive, heterogeneous class of compounds.